| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/23/2011 | CN101987173A Traditional Chinese medicine for treating diabetic oculopathy |
| 03/23/2011 | CN101987169A Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus |
| 03/23/2011 | CN101987164A Traditional Chinese medicine for treating diabetic diarrhea |
| 03/23/2011 | CN101987161A Traditional Chinese medicine for treating diabetic gout |
| 03/23/2011 | CN101987140A Traditional Chinese medicine health-care tea for preventing and treating hyperlipidaemia |
| 03/23/2011 | CN101987139A Traditional Chinese medicine for treating diabetic nephropathy |
| 03/23/2011 | CN101987134A Traditional Chinese medicine for treating diabetic retinopathy |
| 03/23/2011 | CN101987119A Traditional Chinese medicine for treating diabetic cutaneous pruritus |
| 03/23/2011 | CN101987113A Thickening and stable animal iron-supplement composition |
| 03/23/2011 | CN101987093A Ferrous lactate gel skeleton slow-release preparation and preparation method thereof |
| 03/23/2011 | CN101703686B Chinese medicinal composition for treating diabetes |
| 03/23/2011 | CN101632818B Traditional Chinese medicine medicinal powder for treating diabetes and preparation method thereof |
| 03/23/2011 | CN101601646B Nasal cavity drop for treating diabetes and preparation method thereof |
| 03/23/2011 | CN101428136B Uses of recombinant protein in preparing oral medication for preventing diabetes |
| 03/23/2011 | CN101422431B Insulation administration preparation through nose |
| 03/23/2011 | CN101361802B Traditional Chinese medicine formulation for treating diabetes complication disease |
| 03/23/2011 | CN101357952B Polysaccharide MA from Mytilus coruscus with hypolipidemic activity and preparation method thereof |
| 03/23/2011 | CN101357924B Dipeptidase-IV inhibitor compound |
| 03/23/2011 | CN101357923B Dipeptidase inhibitor compound |
| 03/23/2011 | CN101328221B Hypoglycemic polypeptide fused protein, structure and use of derivate thereof |
| 03/23/2011 | CN101293059B Compound Chinese medicine for treating diabetes |
| 03/23/2011 | CN101129394B New use of aesculin in preventing and/or treating cardiovascular disease |
| 03/23/2011 | CN101084943B Method for preparing mixture containing natural vitamin P from sea-buckthorn |
| 03/23/2011 | CN101062348B Ganoerma lucidum capusule for reducing blood sugar |
| 03/23/2011 | CN101053437B Organic germanium Ge-132 glossy ganoderma beverage and processing method |
| 03/23/2011 | CN101032564B Health preserving wine for conditioning blood-fat and the preparing method |
| 03/23/2011 | CN101006857B Products of nutrients for bones and preparation method |
| 03/22/2011 | US7910709 Thyroid stimulating hormone for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 03/22/2011 | US7910707 Anti-interferon-α antibodies |
| 03/22/2011 | US7910615 Prophylactic or therapeutic agent for diabetic maculopathy |
| 03/22/2011 | US7910605 Administering tertiary amines, e.g., 3,3-Dimethylbutyl 3-piperidinopropyl ether, 3-Phenylpropyl 3-piperidinopropyl ether, or3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether to treat cognitive disorders such as attention, wakefulness and memory disorders |
| 03/22/2011 | US7910601 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 03/22/2011 | US7910589 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 03/22/2011 | US7910548 Methods for treating obesity |
| 03/22/2011 | US7910545 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases |
| 03/22/2011 | US7910370 Treating and preventing cell proliferative, neurodegenerative and viral infections via enhancing oncogenic protein expression |
| 03/22/2011 | CA2622334C Thiophene derivatives for the treatment of diabetes |
| 03/22/2011 | CA2614443C Pyrido [2,3-d] pyrimidine-2,4-diamine compounds as ptp1b inhibitors |
| 03/22/2011 | CA2492342C Novel bio-active pyrimidine derivatives |
| 03/22/2011 | CA2490531C Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity |
| 03/22/2011 | CA2488001C 1,5-distributed pyrrolid-2-one derivatives for use as ep4 receptor agonists in the treatment of eye diseases such as glaucoma |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2479363C Thiopyrimidine and isothiazolopyrimidine kinase inhibitors |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2471538C Pyrrolopyrimidines |
| 03/22/2011 | CA2450587C Natural ligand of g protein coupled receptor chemr23 and uses thereof |
| 03/22/2011 | CA2445333C Quinoline derivatives and quinazoline derivatives having azolyl group |
| 03/22/2011 | CA2433675C Pharmaceutically active piperidine derivatives |
| 03/22/2011 | CA2397294C Glyburide composition |
| 03/22/2011 | CA2379357C Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 03/22/2011 | CA2344690C Fructosamine oxidase: antagonists and inhibitors |
| 03/17/2011 | WO2011031111A2 Alkoxy indole-3-acetic acid derivative acting as ppar α/γ/δ agonists, preparation method thereof, and pharmaceutical composition containing same as active ingredient |
| 03/17/2011 | WO2011031063A2 Composition for preventing or treating metabolic disorders, containing the anti-4-1bb antibody |
| 03/17/2011 | WO2011030139A1 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
| 03/17/2011 | WO2011029870A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes |
| 03/17/2011 | WO2011029827A1 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents |
| 03/17/2011 | WO2011029808A1 Hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | WO2011029803A1 2 -aminodihydro [1, 3] thiazines as bace 2 inhibitors for the treatment of diabetes |
| 03/17/2011 | WO2011029359A1 MEDICAMENTS CONTAINING 11β HYDROXYSTEROID DEHYDROGENASE 1 DOUBLE REGULATORS AND USES THEREOF |
| 03/17/2011 | WO2010133211A4 Decolorized extracts of the plant pandanus conoideus |
| 03/17/2011 | WO2010120508A3 Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders |
| 03/17/2011 | WO2010066687A3 Stabalized statin-comprising compositions |
| 03/17/2011 | WO2008102208A3 Inhibition of platelet aggregation |
| 03/17/2011 | US20110065918 New phenylalanine derivatives |
| 03/17/2011 | US20110065800 Formulations for cathepsin k inhibitors |
| 03/17/2011 | US20110065780 Insulin resistance improving agent |
| 03/17/2011 | US20110065775 Compounds and methods for modulating expression of sglt2 |
| 03/17/2011 | US20110065761 Methods of treating nerve-related vision disorders |
| 03/17/2011 | US20110065759 5-(3,4-dichloro-phenyl)-n-(2-hydroxy-cyclohexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide and salts thereof |
| 03/17/2011 | US20110065757 Methods for treatment of kallikrein-related disorders |
| 03/17/2011 | US20110065756 Methods and compositions for treatment of obesity-related diseases |
| 03/17/2011 | US20110065743 Kappa opioid receptor ligands |
| 03/17/2011 | US20110065739 Novel isoxazole drivative |
| 03/17/2011 | US20110065736 Quinazoline derivatives as vegf inhibitors |
| 03/17/2011 | US20110065731 Uses of dpp-iv inhibitors |
| 03/17/2011 | US20110065728 Lipoprotein lipase-activating compositions comprising benzene derivatives |
| 03/17/2011 | US20110065724 Compounds that modulate intracellular calcium |
| 03/17/2011 | US20110065720 Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases |
| 03/17/2011 | US20110065707 New hsl inhibitors useful in the treatment of diabetes |
| 03/17/2011 | US20110065706 Therapeutic Agents 812 |
| 03/17/2011 | US20110065703 Novel agents of calcium ion channel modulators |
| 03/17/2011 | US20110065697 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 03/17/2011 | US20110065695 Use of aminodihydrothiazines for the treatment or prevention of diabetes |
| 03/17/2011 | US20110065694 Histamine H3 Inverse Agonists and Antagonists and Methods of Use Thereof |
| 03/17/2011 | US20110065675 Azo dye related small molecule modulators of protein-protein interactions |
| 03/17/2011 | US20110065671 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| 03/17/2011 | US20110065668 Phenylpyrazole derivatives |
| 03/17/2011 | US20110065667 Phenylpyrazole derivatives |
| 03/17/2011 | US20110065660 Chemosensory Receptor Ligand-Based Therapies |
| 03/17/2011 | US20110065635 Methods and compositions for modulating insulin regulation |
| 03/17/2011 | US20110065634 Glucagon receptor antagonists, compositions, and methods for their use |
| 03/17/2011 | US20110065633 Ester-based peptide prodrugs |
| 03/17/2011 | US20110065632 Pharmaceutical compositions of somatostatin-dopamine conjugates |
| 03/17/2011 | US20110065628 Medication Combinations for the Treatment of Alcoholism and Drug Addiction |
| 03/17/2011 | US20110065187 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065186 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065180 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease |
| 03/17/2011 | US20110065147 Methods and reagents for modulating cholesterol levels |
| 03/17/2011 | US20110065132 Identification of Actinobacillus actinomycetemcomitans Antigens for use in the Diagnosis, Treatment and Monitoring of Periodontal Diseases |
| 03/17/2011 | US20110064833 Synergistic herbal composition and process of preparation thereof |